Leadership

1987-1992 - Assistant professor of Neurology, University of Colorado School of Medicine, Denver, Colorado
1992-1998 - Associate Professor of Neurology, Louisiana State University School of Medicine, New Orleans, LA
1998-2001 - Professor of Neurology and Neuroscience, Louisiana State University School of Medicine, New Orleans, LA
2006-2007 - Clinical Professor of Neurology, University of Washington, Seattle, WA
2007 - Present Professor and Chair of Neurology/Neuroscience, Louisiana State University Health Sceinces School of Medicine, New Orleans, LA
2008-2014 - Professor and Chair of Neurology/Neuroscience, Grace Benson Professor of Neurology, Louisiana State University Health Sceinces School of Medicine, New Orleans, LA
2014 - Present Professor and Chair of Neurology/Neuroscience, Richard M. Paddison Professor of Neurology, Louisiana State University Health Sceinces School of Medicine, New Orleans, LA

Awards

2001-2003 - President, American Academy of Clinical Neurophysiology
2009-2010 - President, American Association of Neuromuscular and Electrodiagnostic Medicine
2016 - Distinguished Physician Award from the American Association of Neuromuscular & Electrodiagnostic Medicine
2016-2020 - Chair, American Board of Electrodiagnostic Medicine
2017 - Honorary Member of the French Society of Neurology (Membres d’honneur a titre etranger de la Societe Francais de Neurologie)
2017 - Director, Center of Excellence for GBS/CIPD
2019-2022 - Councilor, Association of University Professors of Neurology

Editions

Editor-in-Chief for the Journal of the Neurological Sciences, the official journal of the World Federation of Neurology
Editor-in-Chief for the Encyclopedia of the Neurological Sciences 3rd Edition

Publications

1. Medina, M.T., England, J.D., Lorenzana, I., Alvarado, M.M.D., Fontiveros, M.DeB.S., Sierra, M., Contreras, F. “Zika virus associated with sensory polyneuropathy.” Journal of the Neurological Sciences, Vol. 369, October 2016, 271-272.

2. Bodofsky, E.B., Carter, G.T., England, J.D. “Is electrodiagnosis testing for polyneuropathy overutilized?” Muscle Nerve, Vol. 55, March 2017, 301-304.

3. Soliman, M.Y, El-Abassi, R., England, J.D. Diagnosis and treatment of Fabry’s disease from a neurologic perspective. J Rare Dis Res Treat, Vol 2(1), 2016, 12-18.

4. Technical Expert. Agency for Healthcare Research and Quality U.S. Department of Health and Human Services. Johns Hopkins University Evidence – based Practice Center. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy. Comparative Effectiveness Review. Number 187, March 2017.

5. El-Abassi, R., Soliman, M.Y., Williams, F., England, J.D. Whipple’s Disease. Journal of the Neurological Sciences, e pub, 15 January 2017.

6. Gelinas D., Katz J., Nisbet P., England J.D. Current practice patterns in CIDP: A cross- sectional survey of neurologists in the United States. Journal of the Neurological Sciences, Vol 397, 2019, 84-91.

7. Zambrano, L. I., Vasquez-Bonialla, W. O., Fuentes-Barahona, I. C., da Silva, J. C., Valle-Reconco, J. A., Medina, M. T., England, J. D., Sanchez-Duque, J. A., Rodriguez-Morales, A. J. Spatial Distribution of Zika in Honduras during 2016-2017 using Geographic Information System (GIS) – Implication in public health and travel medicine. Travel Medicine and Infectious diseases. 31 Jan. 2019.

8. El-Abassi, R., Soliman, M.Y., Villemarette-Pittman, N., England J.D. SPS: Understanding the complexity. Journal of the Neurological Sciences, 2019; Vol 404: 137-149.

9. England, J., Jacobs, B., Leger, JM. Improving Intravenous Immunoglobulin (IVIG),Dosing in Autoimmune Neuropathies. European Medical Journal. 24 June 2019.

10. Bodofsky E., England J.D. Using Symmetry to optimize the Diagnosis of Bilateral Carpal Tunnel Syndrome by Nerve Conduction Testing. “In Press.”

11. Ortiz Quezada J.A., Gonzales E.E., Molina L., Duran C., Lorenzana I., Bautista C., Hesse H., England J.D. Chikungunya encephalitis: A case series from an endemic country. Journal of the Neurological Sciences 15 Jan 2021; 420, 117279:1-5.

12. Levy M.H., England J.D. The evaluation of polyneuropathy. Best Practices: British Medical Journal 2021 (bestpractice.bmj.com)

13. Mader E.C., Rathore S.H., England J.D., Branch L., Copeland B.J. Benzodiazepine withdrawal catatonia, delirium and seizures in a patient with schizoaffective disorder. Journal of Investigative Medicine. 2021.

14. Medina M.T., Meshram C., England J., Shakir R. Tropical Neurology Education: A World Federation of Neurology outstanding priority. Journal of the Neurological Sciences 2021; 421:117281.

15. Sanchez O., Marcela Portillo K., Reyes-Garcia S. Z., England J.D., Medina MM T., Characterization of adult patients with Guillain-Barre Syndrome during the arboviral infection outbreak in Honduras. Journal of the Neurological Sciences. In Press. 20 June 2021; 427: 117551.

Research

2016–2020 - Chair of Task Force on Zika Virus for World Federation of Neurology (WFN) and World Health Organization (WHO) with Focus on the Neurology Complications.

2010-2014 - Co-Chair, Muscular Dystrophy Guidelines Development Panel. A collaborative project of the American Academy of Neurology, the Centers for Disease Control and Prevention (CDC) and the American Association of Neuromuscular and Electrodiagnostic Medicine, 2010-1014. Funded by the CDC.

2010-2016 - Co-Investigator for “Lyme Neuroborreliosis in the Rhesus Monkey.” Funded by NIH-NINDS (Grant No. 5R01 NS0489 52-06).

2006 - Principal Investigator for “Bi-axial rotating magnetic field therapy in refractory neuropathic foot pain, a randomized, double-blind, placebo-controlled trial.” Sponsored by Nu Magnetics, Inc.

2006 - Principal Investigator for “A multi-center, randomized, double-blind, placebo- controlled, parallel group, 13-week, adaptive design study on 4 fixed oral doses of DVS SR in adult outpatients with pain associated with diabetic peripheral neuropathy.” Sponsored by Wyeth Research Division (Protocol No. 3151A5-322-US).

2006 -  Principal Investigator for “[S.S] – reboxetine does – range finding trial: A 16-week, randomized, double-blind, placebo and pregabalin controlled, multi- center trial of [S.S] – reboxetine in patients with postherpetic neuralgia.” Sponsored by Pfizer, Inc. (Protocol No. PNU-1654426).

2005 - Principal Investigator for “A multi-center, randomized, double blind, placebo-controlled, parallel group study to evaluate the safety and efficiency of lamotrigine 200-400 mg/day compared with placebo in subjects with painful diabetic neuropathy.” Sponsored by Glaxo Smith Kline. (Protocol No. NPP101982).

2005 - Consultant for “Effects of arzoxifene on vertebral fracture incidence and on invasive breast cancer incidence in postmenopausal women with osteoporosis or with low bone density.” Sponsored by Eli Lilly and Company (Protocol H4Z – MC – GJAD) (The GENERATIONS Study).